Fundraising FoxLifespan Vision Ventures
Venture capitalNorwalk · Pre-Seed–Series A · 1 people tracked
Find your way into Lifespan Vision Ventures
Sign up to find every way you can get introduced to Lifespan Vision Ventures
- Your email: who you already know at Lifespan Vision Ventures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Lifespan Vision Ventures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Lifespan Vision Ventures focuses on early-stage biotechnology companies developing breakthrough therapeutics aimed at preventing and treating age-related diseases. The firm backs founders advancing science-driven solutions that promote healthy aging and extend human healthspan, investing globally in companies working on longevity and chronic disease interventions.
Source: firm website, verified Oct 2, 2026.
Team · 1 people
from the firm's websiteWhat they invest in
from 15 of 22 portfolio companiesBiotech ×15Healthtech ×9Deep Tech ×8Longevity ×8AI & Machine Learning ×7Medical Devices ×2Digital Health ×1
HQs:United States×12United Kingdom×1
Who they back
founder profiles across 11 portfolio companiesFounding team size:solo founder×42 founders×33 founders×4
Where their founders studiedfrom 14 founders with education data
Caltech ×2Columbia Engineering ×2Columbia University ×2University of California, Berkeley ×2
What their founders studiedfrom 15 founders with field-of-study data
Life Sciences ×9Engineering ×4Computer Science ×3Physics ×3Business & Management ×2
Where their founders worked beforefrom 15 founders with career history
Biotech CEO Sisterhood ×2Wyss Institute for Biologically Inspired Engineering ×2
Accelerator rootsportfolio companies that came through a program
Investments · 22 tracked
founders shown can be your intro path
Algen Biotechnologies discovers and develops small molecule therapeutics for cancer and inflammatory diseases using CRISPR, RNAi, and machine learning to decode functional gene networks and predict drug responses.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Chun-Hao Huang(Founder)inChristine Du(Founder)inJennifer DoudnaDr. Jeff Whitten(Chief Scientific Officer)
Co-investorsCota CapitalDraper AssociatesRebel FundY CombinatorSequoia CapitalViking Global
BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development.
AI & Machine LearningBiotechDeep TechLongevity
Dr. Peterson
Co-investorsBioGenerator VenturesMissouri Technology CorporationquadraScope Venture Fund
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.
BiotechDigital HealthLongevitySan Francisco, US
Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in
BoardDylan Morris(Director)in
Co-investorsage1Bold Capital PartnersCornucopian Capital ManagementCRV (Charles River Ventures)Owl CapitalquadraScope Venture Fund+2 more
EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.
BiotechHealthtechMedical DevicesNew York, US
Nina Tandon(Co-Founder, CEO)inSarindr Bhumiratana(Co-Founder)inGordana Vunjak-Novakovic(Director)Elma Hawkins(Director)
BoardRobert Langer(Director)David Zhu(Director)in
Co-investorsBeresford VenturesEMV CapitalHackensack Meridian Health Bear's DenKendall Capital PartnersMEDA AngelsPlum Alley Investments+2 more
Fauna Bio applies AI and computational analysis to its proprietary biobank of data from extreme mammals such as hibernating species to identify drug targets that are conserved across species including humans.
AI & Machine LearningBiotechDeep TechHealthtechEmeryville, US
Linda Goodman(Founder)inAshley(CEO)
Co-investorsage1Farvatn VentureGRIDS CapitalLifeforce CapitalMetaplanetPalo Santo VC+5 more
General Proximity develops proximity-based technologies for drug discovery and development.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Armand Cognetta(Founder)in
Co-investorsY Combinatorage1Felicis VenturesModi VenturesCoughdrop CapitalRock Creek Capital+1 more
Immunis Biomedical develops multi-active biologics based on stem cell-derived secretomes — cell-free therapeutics containing proteins, lipids and growth factors — aimed at treating age-related and immune-related diseases.
BiotechHealthtechLongevityIrvine, US
Gabriel Nistor(Executive Officer)
BoardTakahide Koda(Director)Daniel Kraft(Director)inHans Keirstead(Chairman of the Board)
Co-investorsBold Capital PartnersJLSquadraScope Venture FundRemiges Ventures, Inc.
Integrated Biosciences is a biotech company developing treatments and interventions for aging-related diseases using a combination of medicinal chemistry, biochemistry, aging biology, and artificial intelligence.
AI & Machine LearningBiotechLongevity
Daniel J. Anderson(Chief Scientific Officer)inSean Brown(Head of Medicinal Chemistry)inDan Whalen(Head of Biochemistry)inSatotaka Omori(Head of Aging Biology)inAlex Peysakhovich(Head of AI)in
Co-investorsSutter Hill VenturesPage One Ventures
Modulo is a biotech company focused on the neuroimmune system, developing treatments for brain and central nervous system disorders.
AI & Machine LearningBiotechDeep TechLos Altos, US
Mike Horowitz(CEO & Co-founder)Justin Ichida(Co-founder)inScott Patterson(CTO & Co-founder)inJoe Wagner(Chief Development Officer)
BoardAlda Leu Dennis(Director)inNicholas Saccomano(Director)
Co-investorsCantos VenturesHAWKTAILInitialized CapitalSpacecadet VenturesBiovergeBuilders VC+1 more
Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.
BiotechHealthtechLongevitySan Diego, US
Noah Davidsohn(CSO, Co-Founder)inDaniel Oliver(CEO, Co-Founder)inGeorge Church(Co-Founder and SAB)Deborah Ascheim(Chief Medical Officer)in
Co-investorsCompanion FundConnecticut InnovationsDigitalis VenturesKendall Capital PartnersVCapitalKdT Ventures
Rejuvenation develops proprietary mRNA and lipid nanoparticle technology to safely lengthen telomeres in human cells, targeting cellular aging and diseases caused by short telomeres including pulmonary fibrosis, liver disease, and bone marrow failure.
BiotechDeep TechHealthtechLongevitySan Francisco, US
Glenn Markov(Founder)inJohn Ramunas(Founder)in
Co-investorsAsymmetry VenturesStartupsY CombinatorAgrolimen VenturesDevXKhosla Ventures+5 more
Remedium Bio is a biotech company developing gene therapy and biologic treatments for osteoarthritis and other rheumatology and metabolic conditions, drawing on research into cartilage regeneration and the FGF18 protein.
BiotechHealthtechLongevityBoston, US
Co-investorsUlu VenturesHKX Capital
SENISCA is a University of Exeter biotech developing RNA-based senotherapeutics that target dysregulated RNA splicing to reverse cellular senescence and treat age-related disease.
BiotechDeep TechLongevity
Lorna Harries(Founder)in
Co-investorsAPEX VenturesR42 Group
Sift Biosciences develops T-cell immunotherapies for cancer and autoimmune diseases, using an AI-driven discovery platform combined with metagenomics and high-throughput cellular screening to identify microbially derived molecules that activate memory T cells.
AI & Machine LearningBiotechHealthtechSan Carlos, US
Yue Clare Lou(Co-Founder & CEO)in
BoardKevin Barrett(Director)inAltar Munis(Director)
Co-investorsEisai Innovation, Inc.SBI HoldingsFifty YearsFREEFLOW
Violet is a therapeutics company developing small molecule treatments for central nervous system diseases, using its proprietary C-to-C Engine platform to identify disease-relevant cell-to-cell interactions.
BiotechDeep TechCambridge, US
Co-investorsDementia DiscoveryDementia Discovery FundOno Venture Investment, Inc.SV Health InvestorsUTEC
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
NanoticsRemedium Bio
Portfolio news
latest coverage across their companiesRemedium · finsmes.com · Aug 10, 2026
Rejuvenate Bio · finsmes.com · Jun 8, 2026
Frequently asked questions
- How many investments has Lifespan Vision Ventures made?
- Lifespan Vision Ventures has 22 tracked investments.
- What stage does Lifespan Vision Ventures invest at?
- Lifespan Vision Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Lifespan Vision Ventures focus on?
- Lifespan Vision Ventures focuses on Biotech, Healthtech, Longevity.
- Where is Lifespan Vision Ventures located?
- Lifespan Vision Ventures is headquartered in Norwalk, US.
- Who does Lifespan Vision Ventures co-invest with?
- Lifespan Vision Ventures most often shares deals with quadraScope Venture Fund, age1, Y Combinator, among 54 tracked co-investors.
Similar investors
Boundary Capital invests in high-growth private technology companies with the aim of positively impacting millions of lives, focusing on life sciences, AI, and engineering.
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
AlleyCorp is an early-stage investor and incubator based in New York that builds and backs companies across enterprise, consumer, healthcare, and deep tech sectors.
Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.